Embodied Revelation: A Classic Grounded Theory of Heart Failure Patient Decision Making Surrounding Primary Prevention Implantable Cardioverter Defibrillator Therapy
Main Article Content
Abstract
The purpose of this classic grounded theory study was to explain the complex decision making process of heart failure (HF) patients considering primary prevention implantable cardioverter defibrillator (ICD) therapy. Sudden cardiac death (SCD) is the leading cause of death for people with HF as well as the primary cause of death in the United States (US). ICDs represent the standard of care as the only effective therapy for primary prevention of SCD. However, a significant proportion of qualifying HF patients declines this invasive, yet life-saving device. The grounded theory is of Embodied revelation. The threat of SCD for ICD candidates consists of four stages: living in conscious denial, heightening of awareness, sanctioning ICD therapy, and living in new assurance. The first stage ends abruptly with the critical juncture of grasping the threat of SCD. This grounded theory has implications for research, nursing and medical practice, as well as bioethical considerations.
Downloads
Article Details
The Grounded Theory Review is an open-access journal, which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the international Budapest Open Access Initiative (BOAI) definition of open access.
References
American Heart Association. (2010). Heart disease and stroke statistics 2009 update. Dallas, TX: American Heart Association.
Bardy, G.H., Lee, K.L., Poole, J.E., Packer, D.L., Boineau, R., Domanski, M., . . . Ip, J.H. (2005). For the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352 (3), 225-237.
Beauchamp, T.L., & Childress, J. (2012). Principles of biomedical ethics. New York, NY: Oxford University Press.
Charmaz, K. (1991). Good days, bad days: The self in chronic illness and time. New Brunswick, NJ: Rutgers University Press.
Duray, G., Israel, C.W., & Hohnloser, S.H. (2006). Recent primary prevention implantable cardioverter defibrillator trials. Current Opinion in Cardiology, 21(1), 9-15.
Echt, D.S., Liebson, P.R., Mitchell, L.B., Peters, R.W., Obias-Manno, D., . . . Greene, H.L (1991). Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. The New England Journal of Medicine, 324(12), 781-788.
Elwyn, G. & Miron-Satz, T. (2009). Deliberation before determination: The definition and evaluation of good decision making. Health Expectation, 13, 139-147. Embodied [Def. 2]. (n.d.) In Merriam Webster online, Retrieved from www.merriam-webster.com/dictionary/embody
Gillespie, R. (1991). Manufacturing knowledge: A history of the Hawthorne experiments.Cambridge, UK: Cambridge University Press.
Glaser, B.G. (1978). Theoretical sensitivity: Advances in the methodology of grounded theory. Mill Valley, CA: Sociology Press.
Glaser, B.G. (1998). Doing grounded theory: Issues & discussions. Mill Valley, CA: Sociology Press.
Glaser, B.G. (2002). Conceptualization: On theory and theorizing using grounded theory. International Journal of Qualitative Methods, 1(2), 1-31.
Gravelin, L.M., Yuhas, J., Remetz, M., Radford, M., Foley, J. & Lampert, R. (2011). Use of a screening tool improves appropriate referral to an Electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Circulation, 4, 152-156.
Guthrie, W., & Lowe, A. (2011). Getting through the PhD process using Grounded Theory: A supervisor-researcher perspective. In V.B. Martin & A. Gynnild (Eds.), Grounded theory, the philosophy, method, and work of Barney Glaser (pp. 51-68). Boca Raton, FL: Brown Walker Press.
Gynnild, A. (2011). Atmosphering the conceptual discovery. In V.B. Martin & A. Gynnild (Eds.), Grounded theory, the philosophy, method, and work of Barney Glaser. (pp. 31-49). Boca Raton, FL: Brown Walker Press.
Hernandez, A.F., Fonarow, G.C., Liang, L., Al-Khatib, S.M., Curtis, L.H., LaBresh, K.A., . . .Peterson, E.D. (2007). Sex and racial differences in the use of implantable cardioverter defibrillators among patients hospitalized with heart failure. Journal of the American Medical Association, 298(13), 1525-1531.
Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S., Ganiats, T. G., . . . Riegel, B. (2005). ACC/AHA 2005 guidelines update for the diagnosis and management of chronic heart failure in the adult. A report of the American College of Cardiology/ The American Heart Association task force on practice guidelines (writing committee to up-date the 2001 guidelines for the evaluation and management of heart failure). Circulation, 112, e154-e235.
Lakshamanadoss, U.,Sherazi, S. , Aggarwal, A., His, D., Aktor, M.K., Daubert, J.P., & Shah, A.H. (2011). Underutilization of cardioverter defibrillators in primary prevention of sudden cardiac death. Cardiology Research, 2 (1), 1-6. doi:10.4021/cr13w
LaPointe, N.M., Al-Khatib, S.M., Piccini, J.P., Atwater, B.D., Honeycutt, E., Thomas, K., . . . Peterson, E.D. (2011). Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction. Circulation: Cardiovascular Quality & Outcomes, 4 (2), 146-151.
Lincoln, Y., & Guba, E. (1985). Naturalistic inquiry. London, UK: SAGE.
Martin, V.B., & Gynnild, A. (Eds.). (2011). Grounded theory-the philosophy, method, and work of Barney Glaser. Boca Raton, FL: Brown Walker Press.
Moss, A.J., Zaraba, W., Jackson, W., Klein, H., Wilberg, D.J., Cannon, D.S., . . . Andrews, B.B. for the Multicenter Automatic Defibrillator Implantation Trial II investigators. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and re-duced ejection fraction. New England Journal of Medicine, 346, 877- 883.
Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., . . .Turner, M.B. (2015). Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation, 131. doi:10.1161/CIR.0000000000000152
Newman, M.A., Sime, A.M., & Corcoran-Perry, S.A. (1991). The focus of the discipline of nursing. Advances in Nursing Science, 14, 1-6.
Reed, P.G. (1995). A treatise on nursing knowledge development for the 21st century: Beyond postmodernism. Advances in Nursing Science, 17, 70-84.
Ridley, A. (1998). Beginning bioethics. New York, NY: St. Martin’s Press.
Ruskin, J.N., Camm, A.J., Zipes, D.P., Hallstrom, A.P., & McGrory-Usset, M.E. (2002). Implantable cardioverter defibrillator utilization based on discharge diagnoses from medicare and managed care patients. Journal of Cardiovascular Electrophysiology, 13(1), 38-43.
Sandelowski, M. (1995). Qualitative analysis: What it is and how to begin. Research in Nursing & Health, 18 (4), 371-375.
Sudden Cardiac Arrest Foundation. (2015). Retrieved from http://www.sca-aware.org
Thomas, K.L., Al-Khatib, S.M., Kelsey, R.L., Bush, H., Brosius, L., Velazquez, E.J., . . .Gilliam, F.R. (2007). Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction < 35%. American Journal of Cardiology, 16(1), 77-84.
Van Welsenes, G.H., van Ries, J.B., Borleffs, C.J., Cannegieter, S.C., Bax, J.J., van Ewen, L.,. . . Schalji, M. J. (2011). Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace, 13(3), 389-394.
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Drazner, M.H., . . . Wilkoff, B.L. (2013). 2013 ACCF/AHA guidelines for the management of heart failure. A report of The American College of Cardiology Foundation/American Heart Association taskforce on practice guidelines. Circulation, 128, e240-3327, doi:10.1161/CIR.obo13E31829e8776